ClinConnect ClinConnect Logo
Search / Trial NCT06165705

Treating Amblyopia With CureSight

Launched by ALASKA BLIND CHILD DISCOVERY · Dec 4, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Refractive Amblyopia, Strabismic Amblyopia, Anisometropia

ClinConnect Summary

This clinical trial, called "Treating Amblyopia With CureSight," is investigating a new home treatment for amblyopia, also known as "lazy eye." The study is looking for patients who have amblyopia and are willing to use a special device called CureSight for about 1.5 hours a day, six days a week, for 3 to 6 months. The goal is to see if this treatment can help improve their vision.

To be eligible for the trial, participants need to have amblyopia, but they should be able to understand and use the device at home, which requires having WiFi access. This trial is open to individuals aged 730 days to 7304 days (which is approximately 2 to 20 years old). If you or someone you know has amblyopia, this could be a chance to try a new treatment that may help improve visual skills in a comfortable home setting.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • amblyopia
  • Exclusion Criteria:
  • lack of brain and eye capacity for improved vision lack of home WiFi

About Alaska Blind Child Discovery

Alaska Blind Child Discovery is a dedicated clinical trial sponsor focused on advancing research and interventions for visually impaired children. Committed to enhancing the quality of life for these children and their families, the organization collaborates with healthcare professionals, researchers, and community stakeholders to develop innovative solutions and evidence-based practices. Through rigorous clinical trials and a patient-centered approach, Alaska Blind Child Discovery aims to uncover new therapeutic avenues, improve educational resources, and foster a supportive environment that empowers visually impaired children to thrive.

Locations

Anchorage, Alaska, United States

Patients applied

0 patients applied

Trial Officials

Robert W Arnold, MD

Principal Investigator

Alaska Blind Child Discovery

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported